by Tina Koutouleas | May 9, 2019 | Biotech, Entrepreneurship, Life Science, Pharma | 0 Comments

Dr. Rafel Simó Vicens has been a part of the REBBLS CORE group since August 2017. He has recently defended his Ph.D which investigated the pharmacological inhibition of KCa2 channels as a new therapeutic target for the treatment of atrial fibrillation. We asked him...

by Tina Koutouleas | April 15, 2019 | Biotech | 0 Comments

How scientists are prone to pigeonholing, stunting collaboration and atomistic problem solving.   A personal commentary by Tina Koutouleas   What is the universe made of? How did life begin? Are we alone in the universe?  What makes us human? Can computers...

by Tina Koutouleas | March 25, 2019 | Biotech | 0 Comments

The CORE team at REBBLS decided that this is the year to shake things up in the Danish Life Science space by producing our very own podcast. This is a short step-by-step guide highlighting how we achieved this. At the end of the article you can find the link to listen...

by Tina Koutouleas | February 27, 2019 | Biotech, Entrepreneurship, Innovation, Life Science | 0 Comments

A personal commentary by Tina Koutouleas What is Biohacking? Biohacking is anything that “hacks” i.e. improves our natural biology from microbe to human by people outside of the usual bounds of research. What comes to mind when you hear the word biohacking? If you had...

by Alexander Moldt Nielsen | February 4, 2019 | Biotech, Entrepreneurship, Innovation | 0 Comments

If you’re working with innovation in a big company chances are that you’ve hit the wall a few times although you felt your project could have good implications for your company by bringing it in a new and better direction. At REBBLS we set out to uncover how...

by master | October 5, 2018 | Biotech, Discovery, Innovation, Life Science, REBBLog | 0 Comments

Photo by Manuel Barroso Parejo on Unsplash Back in June, the EU court came out with its highly anticipated ruling on gene-edited organisms. You might have heard of gene-editing, as specifically the CRISPR technology has been making headlines, not only due to its huge...

by Tina Koutouleas | September 3, 2018 | Biotech | 0 Comments

Stan Cox narrates a brilliantly leery take on modern attitudes relating to sustainability, the dismal search for new markets and the relationship between the double eco - ecology and economics. The piece, published on counterpunch.org at the start of august this year,...